Peter Hoskin
Peter Hoskin
Professor of Clinical Oncology, University of Manchester
Verified email at
Cited by
Cited by
Alpha emitter radium-223 and survival in metastatic prostate cancer
C Parker, S Nilsson, D Heinrich, SI Helle, JM O'Sullivan, SD Fosså, ...
New England Journal of Medicine 369 (3), 213-223, 2013
Abiraterone for prostate cancer not previously treated with hormone therapy
ND James, JS de Bono, MR Spears, NW Clarke, MD Mason, ...
New England Journal of Medicine 377 (4), 338-351, 2017
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial
START Trialists' Group
The Lancet 371 (9618), 1098-1107, 2008
Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline
S Lutz, L Berk, E Chang, E Chow, C Hahn, P Hoskin, D Howell, A Konski, ...
International Journal of Radiation Oncology* Biology* Physics 79 (4), 965-976, 2011
Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting
L Dickinson, HU Ahmed, C Allen, JO Barentsz, B Carey, JJ Futterer, ...
European urology 59 (4), 477-494, 2011
Results of a trial of PET-directed therapy for early-stage Hodgkin’s lymphoma
J Radford, T Illidge, N Counsell, B Hancock, R Pettengell, P Johnson, ...
New England Journal of Medicine 372 (17), 1598-1607, 2015
Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines
M Fallon, R Giusti, F Aielli, P Hoskin, R Rolke, M Sharma, CI Ripamonti
Annals of Oncology 29, iv166-iv191, 2018
Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study
A Sturdza, R Pötter, LU Fokdal, C Haie-Meder, LT Tan, R Mazeron, ...
Radiotherapy and Oncology 120 (3), 428-433, 2016
Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial
KM Ardeshna, P Smith, A Norton, BW Hancock, PJ Hoskin, ...
The Lancet 362 (9383), 516-522, 2003
Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer
PJ Hoskin, AM Rojas, PJ Bownes, GJ Lowe, PJ Ostler, L Bryant
Radiotherapy and Oncology 103 (2), 217-222, 2012
The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies
R Pötter, K Tanderup, C Kirisits, A de Leeuw, K Kirchheiner, R Nout, ...
Clinical and translational radiation oncology 9, 48-60, 2018
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre …
SM de Boer, ME Powell, L Mileshkin, D Katsaros, P Bessette, ...
The lancet oncology 19 (3), 295-309, 2018
Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases
P Price, PJ Hoskin, D Easton, D Austin, SG Palmer, JR Yarnold
Radiotherapy and Oncology 6 (4), 247-255, 1986
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind …
O Sartor, R Coleman, S Nilsson, D Heinrich, SI Helle, JM O'Sullivan, ...
The Lancet Oncology 15 (7), 738-746, 2014
Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study
AJ Swerdlow, CD Higgins, P Smith, D Cunningham, BW Hancock, ...
Journal of the National Cancer Institute 99 (3), 206-214, 2007
Survival with newly diagnosed metastatic prostate cancer in the “docetaxel era”: data from 917 patients in the control arm of the STAMPEDE trial (MRC PR08, CRUK/06/019)
ND James, MR Spears, NW Clarke, DP Dearnaley, JS De Bono, J Gale, ...
European urology 67 (6), 1028-1038, 2015
Non–small cell lung cancer: histopathologic correlates for texture parameters at CT
B Ganeshan, V Goh, HC Mandeville, QS Ng, PJ Hoskin, KA Miles
Radiology 266 (1), 326-336, 2013
Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a …
P Hoskin, O Sartor, JM O'Sullivan, DC Johannessen, SI Helle, J Logue, ...
The Lancet Oncology 15 (12), 1397-1406, 2014
Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression
D Rades, LJA Stalpers, T Veninga, R Schulte, PJ Hoskin, N Obralic, ...
Journal of Clinical Oncology 23 (15), 3366-3375, 2005
Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer
O Sartor, RH Reid, PJ Hoskin, DP Quick, PJ Ell, RE Coleman, JA Kotler, ...
Urology 63 (5), 940-945, 2004
The system can't perform the operation now. Try again later.
Articles 1–20